Deprescribing considerations for central nervous system-active polypharmacy in patients with dementia.
Publication
, Journal Article
Hung, A; Growdon, ME
Published in: J Am Geriatr Soc
February 2025
Duke Scholars
Published In
J Am Geriatr Soc
DOI
EISSN
1532-5415
Publication Date
February 2025
Volume
73
Issue
2
Start / End Page
343 / 346
Location
United States
Related Subject Headings
- Geriatrics
- 52 Psychology
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Hung, A., & Growdon, M. E. (2025). Deprescribing considerations for central nervous system-active polypharmacy in patients with dementia. J Am Geriatr Soc, 73(2), 343–346. https://doi.org/10.1111/jgs.19294
Hung, Anna, and Matthew E. Growdon. “Deprescribing considerations for central nervous system-active polypharmacy in patients with dementia.” J Am Geriatr Soc 73, no. 2 (February 2025): 343–46. https://doi.org/10.1111/jgs.19294.
Hung A, Growdon ME. Deprescribing considerations for central nervous system-active polypharmacy in patients with dementia. J Am Geriatr Soc. 2025 Feb;73(2):343–6.
Hung, Anna, and Matthew E. Growdon. “Deprescribing considerations for central nervous system-active polypharmacy in patients with dementia.” J Am Geriatr Soc, vol. 73, no. 2, Feb. 2025, pp. 343–46. Pubmed, doi:10.1111/jgs.19294.
Hung A, Growdon ME. Deprescribing considerations for central nervous system-active polypharmacy in patients with dementia. J Am Geriatr Soc. 2025 Feb;73(2):343–346.
Published In
J Am Geriatr Soc
DOI
EISSN
1532-5415
Publication Date
February 2025
Volume
73
Issue
2
Start / End Page
343 / 346
Location
United States
Related Subject Headings
- Geriatrics
- 52 Psychology
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences